D-0570-2024 Class II

Recalled by Medisca Inc. — Irving, TX

FDA drug recall D-0570-2024 was initiated by Medisca Inc. on Jun 26, 2024 and is designated Class II. Reason for recall: CGMP Deviations and Presence of Particulate Matter: Glass Affected quantity: 113 bottles.

Recall details

Product Type
Drugs
Report Date
Jul 10, 2024
Initiation Date
Jun 26, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
113 bottles

Product description

Budesonide, USP (Micronized), 500 mg, White to off-white odorless, crystalline powder, Medisca Inc., Plattsburgh, NY, 12901, USA, NDC: 38779-3097-00.

Reason for recall

CGMP Deviations and Presence of Particulate Matter: Glass

Distribution pattern

Nationwide in the USA and Canada

Code information

Lot #s: 202323/G, 202323/H, Exp. 07/31/2026

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0570-2024
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0570-2024. Report a data issue: hello@regdatalab.com.